{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T03:28:37Z","timestamp":1789615717305,"version":"build-2803163510"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T00:00:00Z","timestamp":1700006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T00:00:00Z","timestamp":1700006400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1007\/s00277-023-05547-1","type":"journal-article","created":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T03:01:24Z","timestamp":1700017284000},"page":"813-822","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["A different perspective on PET\/CT before treatment in patients with Hodgkin lymphoma: importance of volumetric and dissemination parameters"],"prefix":"10.1007","volume":"103","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6239-0660","authenticated-orcid":false,"given":"Ay\u015feg\u00fcl","family":"Aksu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kadir Alper","family":"K\u00fc\u00e7\u00fcker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u015eerife","family":"Solmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00fclent","family":"Turgut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,15]]},"reference":[{"issue":"2","key":"5547_CR1","doi-asserted-by":"publisher","first-page":"104","DOI":"10.5114\/wo.2017.68618","volume":"21","author":"E Subocz","year":"2017","unstructured":"Subocz E, Ha\u0142ka J, Dziuk M (2017) The role of FDG-PET in Hodgkin lymphoma. Contemp Oncol (Pozn) 21(2):104\u2013114. https:\/\/doi.org\/10.5114\/wo.2017.68618","journal-title":"Contemp Oncol (Pozn)"},{"issue":"6","key":"5547_CR2","doi-asserted-by":"publisher","first-page":"755","DOI":"10.6004\/jnccn.2020.0026","volume":"18","author":"RT Hoppe","year":"2020","unstructured":"Hoppe RT, Advani RH, Ai WZ, Ambinder RF, Armand P, Bello CM et al (2020) Hodgkin lymphoma, version 2.2020, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw 18(6):755\u2013781","journal-title":"J Natl Compr Canc Netw"},{"issue":"24","key":"5547_CR3","doi-asserted-by":"publisher","first-page":"3746","DOI":"10.1200\/JCO.2007.11.6525","volume":"25","author":"A Gallamini","year":"2007","unstructured":"Gallamini A, Hutchings M, Rigacci L, Specht L, Merli F, Hansen M et al (2007) Early interim 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography is prognostically superior to international prognostic score in advanced-stage Hodgkin\u2019s lymphoma: a report from a joint Italian-Danish study. J Clin Oncol 25(24):3746\u20133752. https:\/\/doi.org\/10.1200\/JCO.2007.11.6525","journal-title":"J Clin Oncol"},{"issue":"9","key":"5547_CR4","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1093\/annonc\/mdi272","volume":"16","author":"NG Mikhaeel","year":"2005","unstructured":"Mikhaeel NG, Hutchings M, Fields PA, O\u2019Doherty MJ, Timothy AR (2005) FDG-PET after two to three cycles of chemotherapy predicts progression-free and overall survival in high-grade non-Hodgkin lymphoma. Ann Oncol 16(9):1514\u20131523. https:\/\/doi.org\/10.1093\/annonc\/mdi272","journal-title":"Ann Oncol"},{"issue":"27","key":"5547_CR5","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.1200\/JCO.2013.54.8800","volume":"32","author":"BD Cheson","year":"2014","unstructured":"Cheson BD, Fisher RI, Barrington SF, Cavalli F, Schwartz LH, Zucca E et al (2014) Recommendations for initial evaluation, staging, and response assessment of Hodgkin and Non-Hodgkin lymphoma: The Lugano classification. J Clin Oncol 32(27):3059\u20133068. https:\/\/doi.org\/10.1200\/JCO.2013.54.8800","journal-title":"J Clin Oncol"},{"issue":"13","key":"5547_CR6","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1182\/blood-2017-07-795476","volume":"131","author":"AS Cottereau","year":"2018","unstructured":"Cottereau AS, Versari A, Loft A, Casasnovas O, Bellei M, Ricci R et al (2018) Prognostic value of baseline metabolic tumor volume in early-stage Hodgkin lymphoma in the standard arm of the H10 trial. Blood 131(13):1456\u20131463. https:\/\/doi.org\/10.1182\/blood-2017-07-795476","journal-title":"Blood"},{"issue":"4","key":"5547_CR7","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1002\/hon.3025","volume":"40","author":"R Durmo","year":"2022","unstructured":"Durmo R, Donati B, Rebaud L, Cottereau AS, Ruffini A, Nizzoli ME et al (2022) Prognostic value of lesion dissemination in doxorubicin, bleomycin, vinblastine, and dacarbazine-treated, interimPET-negative classical Hodgkin Lymphoma patients: a radio-genomic study. Hematol Oncol 40(4):645\u2013657. https:\/\/doi.org\/10.1002\/hon.3025","journal-title":"Hematol Oncol"},{"key":"5547_CR8","doi-asserted-by":"publisher","first-page":"6347404","DOI":"10.1155\/2021\/6347404","volume":"2021","author":"Y Zhou","year":"2021","unstructured":"Zhou Y, Zhu Y, Chen Z, Li J, Sang S, Deng S (2021) Radiomic features of 18F-FDG PET in Hodgkin lymphoma are predictive of outcomes. Contrast Media Mol Imaging 2021:6347404. https:\/\/doi.org\/10.1155\/2021\/6347404","journal-title":"Contrast Media Mol Imaging"},{"issue":"3","key":"5547_CR9","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1007\/s00259-021-05480-3","volume":"49","author":"JJ Eertink","year":"2022","unstructured":"Eertink JJ, van de Brug T, Wiegers SE, Zwezerijnen GJC, Pfaehler EAG, Lugtenburg PJ et al (2022) 18F-FDG PET baseline radiomics features improve the prediction of treatment outcome in diffuse large B-cell lymphoma. Eur J Nucl Med Mol Imaging 49(3):932\u2013942. https:\/\/doi.org\/10.1007\/s00259-021-05480-3","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"5547_CR10","doi-asserted-by":"publisher","first-page":"40","DOI":"10.2967\/jnumed.119.229450","volume":"61","author":"AS Cottereau","year":"2020","unstructured":"Cottereau AS, Nioche C, Dirand AS, Clerc J, Morschhauser F, Casasnovas O et al (2020) 18F-FDG PET dissemination features in diffuse large B-cell lymphoma are predictive of outcome. J Nucl Med 61(1):40\u201345. https:\/\/doi.org\/10.2967\/jnumed.119.229450","journal-title":"J Nucl Med"},{"key":"5547_CR11","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1007\/s00259-014-2961-x","volume":"42","author":"R Boellaard","year":"2015","unstructured":"Boellaard R, Delgado-Bolton R, Oyen WJ, Giammarile F, Tatsch K, Eschner W et al (2015) FDG PET\/CT: EANM procedure guidelines for tumour imaging: version 2.0. Eur J Nucl Med Mol Imaging 42:328\u2013354. https:\/\/doi.org\/10.1007\/s00259-014-2961-x","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"16","key":"5547_CR12","doi-asserted-by":"publisher","first-page":"4786","DOI":"10.1158\/0008-5472.CAN-18-0125","volume":"78","author":"C Nioche","year":"2018","unstructured":"Nioche C, Orlhac F, Boughdad S, Reuz\u00e9 S, Goya-Outi J, Robert C et al (2018) LIFEx: a freeware for radiomic feature calculation in multimodality imaging to accelerate advances in the characterization of tumor heterogeneity. Can Res 78(16):4786\u20134789","journal-title":"Can Res"},{"issue":"5","key":"5547_CR13","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1093\/annonc\/mdt533","volume":"25","author":"HJ Adams","year":"2014","unstructured":"Adams HJ, Kwee TC, de Keizer B, Fijnheer R, de Klerk JM, Littooij AS et al (2014) Systematic review and meta-analysis on the diagnostic performance of FDG-PET\/CT in detecting bone marrow involvement in newly diagnosed Hodgkin lymphoma: is bone marrow biopsy still necessary? Ann Oncol 25(5):921\u2013927. https:\/\/doi.org\/10.1093\/annonc\/mdt533","journal-title":"Ann Oncol"},{"issue":"1","key":"5547_CR14","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1186\/s12885-022-09758-z","volume":"22","author":"L van Heek","year":"2022","unstructured":"van Heek L, Stuka C, Kaul H, M\u00fcller H, Mettler J, Hitz F et al (2022) Predictive value of baseline metabolic tumor volume in early-stage favorable Hodgkin Lymphoma - Data from the prospective, multicenter phase III HD16 trial. BMC Cancer 22(1):672. https:\/\/doi.org\/10.1186\/s12885-022-09758-z","journal-title":"BMC Cancer"},{"issue":"3","key":"5547_CR15","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1097\/MNM.0000000000001324","volume":"42","author":"F Tutino","year":"2021","unstructured":"Tutino F, Puccini G, Linguanti F, Puccini B, Rigacci L, Kovalchuk S et al (2021) Baseline metabolic tumor volume calculation using different SUV thresholding methods in Hodgkin Lymphoma patients: interobserver agreement and reproducibility across software platforms. Nuc Med Com 42(3):284\u2013291. https:\/\/doi.org\/10.1097\/MNM.0000000000001324","journal-title":"Nuc Med Com"},{"issue":"10","key":"5547_CR16","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.3390\/diagnostics12102325","volume":"12","author":"EKA Triumbari","year":"2022","unstructured":"Triumbari EKA, Morland D, Cuccaro A, Maiolo E, Hohaus S, Annunziata S (2022) Classical Hodgkin lymphoma: a joint clinical and PET model to predict poor responders at \u0131nterim assessment. Diagnostics (Basel) 12(10):2325. https:\/\/doi.org\/10.3390\/diagnostics12102325","journal-title":"Diagnostics (Basel)"},{"issue":"9","key":"5547_CR17","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1007\/s00259-014-2783-x","volume":"41","author":"S Kanoun","year":"2014","unstructured":"Kanoun S, Rossi C, Berriolo-Riedinger A, Dygai-Cochet I, Cochet A, Humbert O et al (2014) Baseline metabolic tumour volume is an independent prognostic factor in Hodgkin lymphoma. Eur J Nucl Med Mol Imaging 41(9):1735\u20131743. https:\/\/doi.org\/10.1007\/s00259-014-2783-x","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"5","key":"5547_CR18","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1200\/JCO.2001.19.5.1388","volume":"19","author":"PG Gobbi","year":"2001","unstructured":"Gobbi PG, Ghirardelli ML, Solcia M, Di Giulio G, Merli F, Tavecchia L et al (2001) Image-aided estimate of tumor burden in Hodgkin\u2019s disease: evidence of its primary prognostic importance. J Clin Oncol 19(5):1388\u20131394. https:\/\/doi.org\/10.1200\/JCO.2001.19.5.1388","journal-title":"J Clin Oncol"},{"issue":"8","key":"5547_CR19","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1002\/cncr.20568","volume":"101","author":"PG Gobbi","year":"2004","unstructured":"Gobbi PG, Broglia C, Di Giulio G, Mantelli M, Anselmo P, Merli F et al (2004) The clinical value of tumor burden at diagnosis in Hodgkin lymphoma. Cancer 101(8):1824\u20131834. https:\/\/doi.org\/10.1002\/cncr.20568","journal-title":"Cancer"},{"issue":"3","key":"5547_CR20","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.annonc.2020.11.019","volume":"32","author":"AS Cottereau","year":"2021","unstructured":"Cottereau AS, Meignan M, Nioche C, Capobianco N, Clerc J, Chartier L et al (2021) Risk stratification in diffuse large B-cell lymphoma using lesion dissemination and metabolic tumor burden calculated from baseline PET\/CT\u2020. Ann Oncol 32(3):404\u2013411. https:\/\/doi.org\/10.1016\/j.annonc.2020.11.019","journal-title":"Ann Oncol"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-023-05547-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-023-05547-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-023-05547-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,14]],"date-time":"2024-02-14T10:04:17Z","timestamp":1707905057000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-023-05547-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,15]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["5547"],"URL":"https:\/\/doi.org\/10.1007\/s00277-023-05547-1","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,15]]},"assertion":[{"value":"2 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. This retrospective study was approved by the institutional review board (Approval Number: 2022\/0414).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all patients for being included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}